版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、 HYPERLINK https:/www.MedChemE/Targets/Indoleamine 2,3-Dioxygenase (IDO).html Indoleamine HYPERLINK https:/www.MedChemE/Targets/Indoleamine 2,3-Dioxygenase (IDO).html HYPERLINK https:/www.MedChemE/Targets/Indoleamine 2,3-Dioxygenase (IDO).html 2,3-Dioxygenase HYPERLINK https:/www.MedChemE/Targets/In
2、doleamine 2,3-Dioxygenase (IDO).html HYPERLINK https:/www.MedChemE/Targets/Indoleamine 2,3-Dioxygenase (IDO).html (IDO)Indoleamine 2, 3-dioxygenase (IDO) is an inflammatory cytokine-inducible rate-limiting enzyme of the tryptophan (Trp) catabolism,which is involved in the inhibition of intracellular
3、 pathogen replication as well as in immunomodulation. To date, three types oftryptophan-metabolizing enzymes have been identified: IDO1, IDO2 and tryptophan 2,3-dioxygenase 2.IDO is an intracellular enzyme that is constitutively expressed in several human and mouse cells. Being present in innate imm
4、unecells, such as Mos and dendritic cells (DCs), IDO catalyzes the initial rate-limiting step of tryptophan (Trp) catabolism, thus leadingto the production of immunoregulatory catabolites (collectively known as kynurenines).The IDO gene promoter contains multiple sequence elements that confer respon
5、siveness to proinflammatory mediators, therebydemonstrating the strong correlation between inflammation and induced IDO expression.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/Indoleamine 2,3-Dioxygenase (IDO).html Indoleamine HYPERLINK https:/www.MedChemE/Targets/Indoleamine 2,3-Dioxygenase
6、 (IDO).html HYPERLINK https:/www.MedChemE/Targets/Indoleamine 2,3-Dioxygenase (IDO).html 2,3-Dioxygenase HYPERLINK https:/www.MedChemE/Targets/Indoleamine 2,3-Dioxygenase (IDO).html HYPERLINK https:/www.MedChemE/Targets/Indoleamine 2,3-Dioxygenase (IDO).html (IDO) HYPERLINK https:/www.MedChemE/Targe
7、ts/Indoleamine 2,3-Dioxygenase (IDO).html HYPERLINK https:/www.MedChemE/Targets/Indoleamine 2,3-Dioxygenase (IDO).html Inhibitors HYPERLINK https:/www.MedChemE/rac-ido1-in-5.html (Rac)-IDO1-IN-5Cat. No.: HY-111540A HYPERLINK https:/www.MedChemE/rac-indoximod.html (Rac)-Indoximod(1-Methyl-DL-tryptoph
8、an; (Rac)-NLG-8189) Cat. No.: HY-133897(Rac)-IDO1-IN-5 (Example 1) is a racemate ofIDO1-IN-5. IDO1-IN-5 is a potent, selective andbrain penetrated inhibitor of Indoleamine2,3-Dioxygenase 1 (IDO1) activity, binds toapo-IDO1 lacking heme rather than matureheme-bound IDO1.(Rac)-Indoximod (1-Methyl-DL-t
9、ryptophan) is anindoleamine 2,3-dioxygenase (IDO) inhibitor.Purity: 99.12%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 98.13%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 50 mg HYPERLINK https:/www.MedChemE/s-ido1-in-5.html (S)-IDO1-IN-5C
10、at. No.: HY-111540B HYPERLINK https:/www.MedChemE/s-indoximod.html (S)-Indoximod(1-Methyl-L-tryptophan; (S)-NLG-8189) Cat. No.: HY-N0707(S)-IDO1-IN-5 (Example 1B) is an active S-isomerof IDO1-IN-5. (S)-IDO1-IN-5 binds to IDOL with anIC value less than 1.5 .50(S)-Indoximod (1-Methyl-L-tryptophan) is
11、aninhibitor of indoleamine 2,3-dioxygenase (IDO).(S)-Indoximod can be used for the research ofcancer.Purity: 99.19%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.03%Clinical Data: No Development ReportedSize: 100 mg HYPERLINK https:/www.MedChemE/s-indoximod-d
12、3.html (S)-Indoximod-d3(1-Methyl-L-tryptophan-d3; (S)-NLG-8189-d3) Cat. No.: HY-N0707S HYPERLINK https:/www.MedChemE/bms-986242.html BMS-986242Cat. No.: HY-139204(S)-Indoximod-d3 is the deuterium labeled(S)-Indoximod. (S)-Indoximod(1-Methyl-L-tryptophan) is an inhibitor ofindoleamine 2,3-dioxygenase
13、 (IDO). (S)-Indoximodcan be used for the research of cancer.BMS-986242 is an orally active, potent andselective indoleamine-2,3-dioxygenase 1 (IDO1)inhibitor. BMS-986242 can be used for the researchof cancer.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.42%Clinical Data
14、: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/bmt-297376.html BMT-297376 HYPERLINK https:/www.MedChemE/bmt-297376.html HYPERLINK https:/www.MedChemE/Coptisine.html CoptisineCat. No.: HY-139205(Coptisin) Cat. No.: HY-N0430BMT-297376, the optimized Linr
15、odostat, is a potentIDO1 inhibitor.Coptisine is an alkaloid from Chinese goldthread,and acts as an efficient uncompetitive IDOinhibitor with a K value of 5.8 M and ani IC50value of 6.3 M.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development Reporte
16、dSize: 5 mg, 10 mg, 25 mg HYPERLINK https:/www.MedChemE/Coptisine-chloride.html Coptisine HYPERLINK https:/www.MedChemE/Coptisine-chloride.html HYPERLINK https:/www.MedChemE/Coptisine-chloride.html chloride HYPERLINK https:/www.MedChemE/Coptisine-chloride.html HYPERLINK https:/www.MedChemE/coptisine
17、-sulfate.html Coptisine HYPERLINK https:/www.MedChemE/coptisine-sulfate.html HYPERLINK https:/www.MedChemE/coptisine-sulfate.html SulfateCat. No.: HY-N0736 Cat. No.: HY-N0430ACoptisine chloride is an alkaloid from Chinesegoldthread, and acts as an efficient uncompetitiveIDO Kinhibitor with a i value
18、 of 5.8 M and an IC50value of 6.3 M.Coptisine Sulfate is an alkaloid from Chinesegoldthread, and acts as an efficient uncompetitiveIDO inhibitor with a Ki value of 5.8 M and an IC50value of 6.3 M.Purity: 98.24%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity:
19、98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/INCB-024360.html Epacadostat(INCB 024360) Cat. No.: HY-15689 HYPERLINK https:/www.MedChemE/8-Nitrotryptanthrin.html GNF-PF-3777(8-Nitrotryptanthri
20、n) Cat. No.: HY-100687Epacadostat (INCB 024360) is a potent andselective indoleamine 2,3-dioxigenase 1 (IDO1)inhibitor with an IC of 71.8 nM.50GNF-PF-3777 (8-Nitrotryptanthrin) is a potenthuman indoleamine 2,3-dioxygenase 2 (hIDO2)inhibitor which significantly reduces IDO2activity with K of 0.97 M.i
21、Purity: 99.66%Clinical Data: Phase 3Size: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 98.56%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/hi5.html HI5Cat. No.: HY-146261 HYPERLINK https:/www.MedChemE/IDO/TDO_Inhibitor.
22、html IACS-8968(IDO/TDO Inhibitor) Cat. No.: HY-112164HI5 is a potent tublin and IDO inhibitor, with anIC value of 70 nM in HeLa cells. HI5 inhibit IDO50expression and decrease kynurenine production,leading to stimulating T cells activation andproliferation.IACS-8968 (IDO/TDO Inhibitor) is a dual IDO
23、 andTDO inhibitor, with pIC s of 6.43 for IDO and5098%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.29%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg HYPERLINK https:/www.MedChemE/IDO/TDO_Inhibitor_R-enantiomer.html IACS-8968 HYPERLINK https:/www.MedChemE/IDO/TDO_In
24、hibitor_R-enantiomer.html HYPERLINK https:/www.MedChemE/IDO/TDO_Inhibitor_R-enantiomer.html R-enantiomer(IDO/TDO Inhibitor (R-enantiomer) Cat. No.: HY-112164A HYPERLINK https:/www.MedChemE/IDO/TDO_Inhibitor_S-enantiomer.html IACS-8968 HYPERLINK https:/www.MedChemE/IDO/TDO_Inhibitor_S-enantiomer.html
25、 HYPERLINK https:/www.MedChemE/IDO/TDO_Inhibitor_S-enantiomer.html S-enantiomer(IDO/TDO Inhibitor (S-enantiomer) Cat. No.: HY-112164BIACS-8968 (R-enantiomer) is the R-enantiomer ofIACS-8968. IACS-8968 is a dual IDO and TDOinhibitor, with pIC s of 6.43 for IDO and 550for TDO, respectively.IACS-8968 (
26、S-enantiomer) is the S-enantiomer ofIACS-8968. IACS-8968 is a dual IDO and TDOinhibitor, with pIC s of 6.43 for IDO and 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/IDO-IN-12.html IDO-IN-12 HYPERLINK https:/www.MedChemE/IDO-IN-12.html HYPERLINK https:/www.M
27、edChemE/ido-in-13.html IDO-IN-13Cat. No.: HY-115122 Cat. No.: HY-129749IDO-IN-12 is an indoleamine 2,3-dioxygenase (IDO)inhibitor extracted from patent WO 2017181849 A1.IDO-IN-13 is a potent indoleamine2,3-dioxygenase 1 (IDO1) inhibitor with an EC50of 17 nM, extracted from patent WO2019040102A1,exam
28、ple 43.Purity: 99.22%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgwww.MedChemE 3 HYPERLINK https:/www.MedChemE/ido-in-14.html IDO-IN-14 HYPERLINK https:/www.MedChemE/ido-in-14.html HYPERLINK https:/www.MedChemE/ido-in-1
29、5.html IDO-IN-15Cat. No.: HY-139653 Cat. No.: HY-139883IDO-IN-14 is an IDO inhibitor with an IC value of500.6928 nM.IDO-IN-15 is an IDO1 inhibitor (IC 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedCh
30、emE/ido-in-16.html IDO-IN-16 HYPERLINK https:/www.MedChemE/ido-in-16.html HYPERLINK https:/www.MedChemE/IDO-IN-3.html IDO-IN-3Cat. No.: HY-142933 Cat. No.: HY-16987IDO-IN-16 (compound 5) is an IDO inhibitor, with anIC of 36 nM.50IDO-IN-3 is a potent indoleamine 2,3-dioxygenase(IDO) inhibitor with an
31、 IC of 290 nM.50Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.88%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 2 mg, 5 mg, 10 mg, 50 mg HYPERLINK https:/www.MedChemE/IDO-IN-4.html IDO-IN-4Cat. No.: HY-18769 HYPERLINK https:/www.MedChemE/IDO-IN-5.html IDO-IN-5(
32、NLG-1489) Cat. No.: HY-18770IDO-IN-4 is an indoleamine 2,3-dioxygenase 1(IDO-1) inhibitor, extracted from patentWO2014150677A1, Compound example 1 enantiomer 1.IDO-IN-5 (NLG-1489) is an indoleamine2,3-dioxygenase (IDO) inhibitor extracted frompatent WO WO2012142237A1, compound 1489, has anIC of 1-10
33、 M.50Purity: 99.40%Clinical Data: No Development ReportedSize: 2 mg, 5 mg, 10 mg, 50 mgPurity: 95.16%Clinical Data: No Development ReportedSize: 5 mg, 10 mg HYPERLINK https:/www.MedChemE/IDO-IN-6.html IDO-IN-6 HYPERLINK https:/www.MedChemE/IDO-IN-6.html HYPERLINK https:/www.MedChemE/NLG919.html IDO-
34、IN-7(NLG-1486) Cat. No.: HY-18770A (NLG-919 analogue; GDC-0919 analogue) Cat. No.: HY-13983IDO-IN-6 (NLG-1486) is an indoleamine2,3-dioxygenase (IDO) inhibitor extracted frompatent WO WO2012142237A1, Compound 1486, has anIC of 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg4 Tel: 609-228-6
35、898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/ido-tdo-in-1.html IDO/TDO-IN-1 HYPERLINK https:/www.MedChemE/ido-tdo-in-1.html HYPERLINK https:/www.MedChemE/IDO1_and_HDAC1_Inhibitor.html IDO1 HYPERLINK https:/www.MedChemE/IDO1_and_HDAC1_Inhibitor.html HYPERLINK https:/www.Me
36、dChemE/IDO1_and_HDAC1_Inhibitor.html and HYPERLINK https:/www.MedChemE/IDO1_and_HDAC1_Inhibitor.html HYPERLINK https:/www.MedChemE/IDO1_and_HDAC1_Inhibitor.html HDAC1 HYPERLINK https:/www.MedChemE/IDO1_and_HDAC1_Inhibitor.html HYPERLINK https:/www.MedChemE/IDO1_and_HDAC1_Inhibitor.html InhibitorCat.
37、 No.: HY-128355 Cat. No.: HY-112147IDO/TDO-IN-1 (compound 25) is a highly potent andorally active dual indoleamine-2,3-dioxygenase(IDO) and tryptophan 2,3-dioxygenase (TDO)inhibitor with IC s of 9.7 and 47 nM,50respectively .IDO1 and HDAC1 Inhibitor (Compound 10) is a dualIDO1 and HDAC1 inhibitor wi
38、th IC s of 69.0 nM and5066.5 nM, respectively.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/ido1-in-11.html IDO1-IN-11 HYPERLINK https:/www.MedChemE/ido1-in-11.html HYPERLINK https:/www
39、.MedChemE/ido1-in-12.html IDO1-IN-12Cat. No.: HY-145332 Cat. No.: HY-145355IDO1-IN-11 is an IDO1 inhibitor with an IC value50of 0.6 nM.IDO1-IN-12 is a potent and orally available IDO1inhibitor.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development R
40、eportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/ido1-in-13.html IDO1-IN-13 HYPERLINK https:/www.MedChemE/ido1-in-13.html HYPERLINK https:/www.MedChemE/ido1-in-14.html IDO1-IN-14Cat. No.: HY-144273 Cat. No.: HY-144274IDO1-IN-13 (compound 27a) is a potent IDO1inhibitor with an IC of 61.6 nM. IDO
41、1-IN-13 has50cellular IDO1 inhibition (HeLa EC = 30 nM).50IDO1-IN-13 decreases 51% of the kyn/trp ratio inSK-OV-3 xenograft tumor tissues.IDO1-IN-14 (compound 4a) is a potent IDO1 inhibitorwith an IC of 396.9 nM. IDO1-IN-14 has cellular50IDO1 inhibition (HeLa EC =3393 nM).50Purity: 98%Clinical Data:
42、 No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/ido1-in-15.html IDO1-IN-15 HYPERLINK https:/www.MedChemE/ido1-in-15.html HYPERLINK https:/www.MedChemE/ido1-in-16.html IDO1-IN-16Cat. No.: HY-144465 Cat. No.: HY-14
43、4466IDO1-IN-15 is a potent IDO1 inhibitor (IC =12750nM). IDO1-IN-15 has comparable potency againstIDO1 enzyme in vitro with Epacadostat.IDO1-IN-16 (I-1) is an IDO1 inhibitor targetingholo-IDO1, with an IC of 127 nM.50Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinica
44、l Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/ido1-in-17.html IDO1-IN-17 HYPERLINK https:/www.MedChemE/ido1-in-17.html HYPERLINK https:/www.MedChemE/ido1-in-2.html IDO1-IN-2Cat. No.: HY-144468 Cat. No.: HY-130607IDO1-IN-17 (I-4) is an IDO1 inhibitor, with an IC50of 0.
45、44 M in hela cells.IDO1-IN-2 (compound 16) is a potent and selectiveIDO1 inhibitor with IC s of 81 nM, 59 nM (mouse)50and 28 nM (rat), respectively. IDO1-IN-2 hasanti-cancer activity.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSiz
46、e: 1 mg, 5 mgwww.MedChemE 5 HYPERLINK https:/www.MedChemE/ido1-in-20.html IDO1-IN-20 HYPERLINK https:/www.MedChemE/ido1-in-20.html HYPERLINK https:/www.MedChemE/LY-3381916.html IDO1-IN-5Cat. No.: HY-146215 Cat. No.: HY-111540Hy-146215 is an enzyme that catalyzes theoxidative metabolism of tryptophan
47、. It canimmunosuppress tumors in the tumormicroenvironment.IDO1-IN-5 is a potent, selective and brainpenetrated inhibitor of IDO1 activity, binds toapo-IDO1 lacking heme rather than matureheme-bound IDO1.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.58%Clinical Data: No
48、 Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/ido1-in-7.html IDO1-IN-7 HYPERLINK https:/www.MedChemE/ido1-in-7.html HYPERLINK https:/www.MedChemE/ido1-2-in-1.html IDO1/2-IN-1Cat. No.: HY-134583 Cat. No.: HY-145280IDO1-IN-7 is a highly potent a
49、nd selectiveindoleamine-2,3-dioxygenase-1 (IDO1) inhibitor,with an IC of 6.1 nM in in the cellular assay50(SKOV3). IDO1-IN-7 has immunomodulatory effects.IDO1-IN-7 can be used for the research of cancer.IDO1/2-IN-1 (compound 4t) is the first potentIDO1/IDO2 dual inhibitor with IC s of 28 nM and50144
50、 nM for IDO1 and IDO2, respectively.IDO1/2-IN-1 exhibits antitumor activies. Orallyactive.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/ido1-tdo-in-1.html IDO1/TDO-IN-1 HYPERLINK https:
51、/www.MedChemE/ido1-tdo-in-1.html HYPERLINK https:/www.MedChemE/IDO5L.html IDO5LCat. No.: HY-144778 Cat. No.: HY-15683IDO1/TDO-IN-1 (30) is a potent dual IDO1(uncompetitive, Ki of 0.23 M) and TDO(competitive, K of 0.73 M) inhibitor.iIDO1/TDO-IN-1 (30) significantly promotes cellapoptosis through the
52、potentialmitochondria-mediated Bcl-2/Bax pathway.IDO5L is a potent indoleamine 2,3-dioxygenase (IDO)inhibitor with an IC of 67 nM.50Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.89%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 10 mg, 50 mg, 100 mg, 500 mg, 1 g
53、 HYPERLINK https:/www.MedChemE/Indoximod.html Indoximod HYPERLINK https:/www.MedChemE/Indoximod.html HYPERLINK https:/www.MedChemE/kushenol-e.html Kushenol HYPERLINK https:/www.MedChemE/kushenol-e.html HYPERLINK https:/www.MedChemE/kushenol-e.html E(1-Methyl-D-tryptophan; NLG-8189) Cat. No.: HY-1672
54、4Cat. No.: HY-N2463Indoximod (1-Methyl-D-tryptophan) is an orallyactive indoleamine 2,3-dioxygenase (IDO) pathwayinhibitor. Indoximod acts as a Trp mimetic inregulating mTOR. Indoximod is an immunometabolicadjuvant used for the research of cancer.Kushenol E is a class of flavonoids isolated fromSoph
55、ora flavescens and is a non-competitiveindoleamine 2,3-dioxygenase 1 (IDO1) inhibitorwith an IC50 of 7.7M and a Ki of 9.5M, hasanti-tumor activity.Purity: 99.39%Clinical Data: Phase 2Size: 250 mgPurity: 96.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/BMS-986
56、205.html Linrodostat HYPERLINK https:/www.MedChemE/BMS-986205.html HYPERLINK https:/www.MedChemE/Navoximod.html Navoximod(BMS-986205; ONO-7701) Cat. No.: HY-101560 (GDC-0919; NLG-919) Cat. No.: HY-18770BLinrodostat (BMS-986205) is a selective andirreversible indoleamine 2,3-dioxygenase 1(IDO1) inhib
57、itor with an IC value of 1.1 nM in50IDO1-HEK293 cells. Linrodostat is well toleratedwith potent pharmacodynamic activity in advancedcancers.Navoximod (GDC-0919; NLG-919) is a potent IDO(indoleamine-(2,3)-dioxygenase) pathway inhibitorwith K/ of 7 nM/75 nM.i EC50Purity: 99.89%Clinical Data: Phase 3Si
58、ze: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 500 mgPurity: 99.99%Clinical Data: Phase 1Size: 10 mM 1 mL, 1 mg, 5 mg, 10 mg6 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/Necrostatin-1.html Necrostatin-1(Nec-1) Cat. No.: HY-15760 HYPERLINK https:/www.Med
59、ChemE/nlg802.html NLG802Cat. No.: HY-145346Necrostatin-1 (Nec-1) is a potent necroptosisinhibitor with an EC of 490 nM in Jurkat50cells. Necrostatin-1 inhibits RIP1 kinase(EC50=182 nM). Necrostatin-1 is also an IDOinhibitor.NLG802 is a prodrug of indoximod, an orally activeindoleamine 2,3-dioxygenas
60、e (IDO) inhibitor.Purity: 99.87%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 10 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/palmatine.html Palmatine HYPERLINK https:/www.MedChemE/palmatine.html HYPERLINK https:/www.MedCh
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 共享服务合同的创新发展趋势展望
- 江苏省江阴市璜土中学高中地理 4.1区域农业发展-以我国东北地区为例教案2 新人教版必修3
- 2024-2025学年高中语文 第四单元 有无相生教案6 新人教版选修《先秦诸子选读》
- 九年级化学下册 第12单元 化学与生活教案 (新版)新人教版
- 2024-2025学年高中历史下学期第13周 罗斯福新政教学设计
- 2024六年级语文下册 第六单元 古诗词诵读 5 江上渔者教学设计+教案+素材 新人教版
- 2024-2025学年上海市浦东新区七年级上英语期中试卷(含答案和音频)
- 雨花石音乐课件
- 发现规律 课件
- 剖宫产手术课件
- 粒子物理基础
- 珠宝首饰制作倒模工艺流程
- 2023年象山县特殊教育岗位教师招聘考试笔试题库及答案解析
- YY/T 1760-2021一次性使用腹膜透析引流器
- GB/T 41365-2022中药材种子(种苗)白术
- GB/T 34570.1-2017电动工具用可充电电池包和充电器的安全第1部分:电池包的安全
- GB/T 12527-2008额定电压1 kV及以下架空绝缘电缆
- 一级建造师考试题库及答案(全国通用)
- 公司社会责任管理制度
- 思想政治工作和文化工作理论1
- 2022届北京市东城区高三语文一模语文试卷讲评课件
评论
0/150
提交评论